You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 284 No. 13, October 4, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Immunization
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Preventing Influenza in Healthy Adults

The Evolving Story

Arnold S. Monto, MD

JAMA. 2000;284:1699-1701.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Inactivated influenza vaccine was originally developed during World War II to protect healthy adult members of the United States armed services. With its major interest in preventing influenza to maintain military readiness, the US military conducted a large number of randomized controlled trials from 1943 through 1969, which demonstrated that the vaccine was 70% to 90% efficacious in preventing laboratory-confirmed clinical influenza as long as the virus in the vaccine resembled the virus that was circulating.1 The current influenza vaccine is similar to the vaccines used in those trials, with higher potency and fewer adverse events. Its efficacy in healthy adults was recently reconfirmed in a randomized trial in which efficacy against laboratory-confirmed influenza was 88%.2

Recommendations for use of influenza vaccine in the United States for years have emphasized prevention of influenza in persons most likely to experience complications: those aged 65 years or older . . . [Full Text of this Article]

Author Affiliation: School of Public Health, University of Michigan, Ann Arbor, Mich.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults: A Randomized Controlled Trial
Carolyn Buxton Bridges, William W. Thompson, Martin I. Meltzer, Gordon R. Reeve, Walter J. Talamonti, Nancy J. Cox, Heather A. Lilac, Henrietta Hall, Alexander Klimov, and Keiji Fukuda
JAMA. 2000;284(13):1655-1663.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Influenza
Cifu and Levinson
JAMA 2000;284:2847-2849.
FULL TEXT  

Should Healthy Individuals Receive Influenza Immunization?
JWatch Infect. Diseases 2000;2000:6-6.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.